MiR-153-5p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Paclitaxel by Inducing G2M Phase Arrest

BACKGROUND: Paclitaxel (PTX) resistance is a main obstacle for the treatment of triple-negative breast cancers (TNBC). Evidences have shown that miR-153-5p could induce the apoptosis of breast cancer cells. Thus, this study aimed to investigate the effect of miR-153-5p on PTX-resistance TNBC cells....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yang, Wu, Nan, Zhang, Jun, Wang, Huidong, Men, Xiaojuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231778/
https://www.ncbi.nlm.nih.gov/pubmed/32494162
http://dx.doi.org/10.2147/OTT.S241640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231778/
https://www.ncbi.nlm.nih.gov/pubmed/32494162
http://dx.doi.org/10.2147/OTT.S241640

Ejemplares similares